- Home
- KNSA vs NATL Comparison
KNSA vs NATL Comparison
Compare KNSA & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | NATL |
|---|---|---|
| Founded | 2015 | 2023 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KNSA | NATL |
|---|---|---|
| Price | $38.58 | $39.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $51.33 | $42.75 |
| AVG Volume (30 Days) | ★ 510.1K | 378.4K |
| Earning Date | 02-24-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.47 | ★ 1.74 |
| Revenue | $597,973,000.00 | ★ $4,322,000,000.00 |
| Revenue This Year | $61.60 | $2.83 |
| Revenue Next Year | $29.82 | $3.96 |
| P/E Ratio | $88.08 | ★ $23.05 |
| Revenue Growth | ★ 55.68 | 0.63 |
| 52 Week Low | $17.82 | $22.30 |
| 52 Week High | $44.42 | $42.23 |
Technical Indicators
Market Signals| Indicator | KNSA | NATL |
|---|---|---|
| Relative Strength Index (RSI) | 36.23 | 56.87 |
| Support Level | $39.16 | $39.08 |
| Resistance Level | $43.00 | $41.06 |
| Average True Range (ATR) | 1.70 | 1.03 |
| MACD | -0.29 | 0.10 |
| Stochastic Oscillator | 6.41 | 63.59 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About NATL NCR Atleos Corporation
NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.